New progress in targeted therapy of pancreatic cancer

Science and Technology Daily News (Reporter Liu Zhiwei, Correspondent Jiang Chaochang) On September 20, the reporter learned from Huazhong Agricultural University that the "Advanced Materials and Green Catalysis" research team led by Professor Chen Hao and Professor Wang Shengyao from the School of Science and the National Nanoscience Center Wang Hao The professor team worked together to design a polypeptide-semiconductor hybrid biosignal processor (BSP) for pancreatic cancer, the "king of cancer", for pancreatic tumor photoacoustic imaging and mitochondrial targeted sonodynamic therapy
.

In cancer treatment, it is an effective method to convert the energy of radiation or non-radiation waves into reactive oxygen species (ROS) through semiconductor nanomaterials to induce tumor cell apoptosis
.

As the basic material of the modern information society, semiconductor materials are excellent receivers and converters for various light, sound, and electrical signals
.

Further in vitro and in vivo experimental studies have shown that BSP integrates the protein signal recognition ability of polypeptide molecules and the physical signal conversion ability of semiconductor materials.